The transformation of the American Diabetes Association (ADA) from a stalwart defender of scientific integrity into an organization that employs security personnel to suppress the distribution of its own journal’s content marks a disturbing chapter in the history of American medical societies. Nearly a decade ago, the ADA was hailed as a beacon of courage in the often-murky waters of scientific publishing. In 2017, the organization received the inaugural "Doing the Right Thing" (DiRT) award from the Center for Scientific Integrity, the parent nonprofit of Retraction Watch. This accolade was not given lightly; it was earned after the ADA successfully fought a high-stakes federal lawsuit brought by a powerful researcher who sought to use the legal system to silence scientific skepticism. Today, however, that same organization finds itself embroiled in a scandal of its own making, accused of "preemptive capitulation" to political interests and the literal policing of medical discourse.
The current crisis traces back to the ADA’s annual meeting earlier in 2026, an event that was meant to showcase the latest breakthroughs in metabolic research but instead became a flashpoint for a debate over free speech and political interference. As reported by STAT, the atmosphere of the conference shifted from academic exchange to authoritarian oversight when police officers and private security personnel intervened to stop a group of physicians and scientists from sharing copies of an opinion piece. The article in question, titled “Misguided Brushes of a Pen Continue to Dismantle,” had been published on April 29 in Diabetes Care, the ADA’s flagship clinical journal. The five individuals, all respected members of the medical community, had their conference badges confiscated and were forcibly ordered to leave the premises. Their crime was not disruptive behavior or harassment; it was the distribution of a peer-reviewed, published commentary that happened to be critical of the federal administration’s stance on science funding.
The ADA’s justification for this heavy-handed response was as confusing as it was concerning. The society claimed that the distribution of these reprints violated its commitment to maintaining a “strictly nonpartisan environment.” This rationale, however, fails to withstand even basic scrutiny. The meeting’s scheduled keynote speaker was Jay Bhattacharya, the director of the National Institutes of Health (NIH) under the Trump administration. The opinion piece being distributed was sharply critical of that same administration’s efforts to slash federal funding for scientific research—funding that the ADA itself ostensibly advocates for. While Bhattacharya eventually withdrew from the event and was replaced by a deputy, the optics remained clear: the ADA appeared to be shielding a high-ranking government official from the very scientific community that his policies impacted.
This incident has sparked a massive internal revolt. More than 200 ADA members, including some of the most prominent names in diabetes research and endocrinology, have signed a petition calling for a radical overhaul of the organization’s leadership. The demands are clear and uncompromising: the immediate resignation of top officials, a comprehensive and independent investigation into the events at the annual meeting, a formal and public apology to the evicted attendees, and a structural guarantee of editorial independence for Diabetes Care. While the ADA has issued a preliminary apology, many members view it as a hollow gesture, especially as the organization continues to hide behind a pending report from its audit and governance committee.
To understand why this shift is so jarring, one must look back to 2015, an era that now feels like a different epoch in the realm of scientific freedom. At that time, the ADA was involved in a grueling legal battle with Mario Saad, a prominent researcher in São Paulo, Brazil. Saad had sued the ADA in U.S. federal court after the journal Diabetes issued expressions of concern regarding four of his published articles. Saad’s legal team alleged that the journal’s actions were "unfair and a persecution," even suggesting that the researcher was being targeted due to his South American heritage.
In the world of scientific publishing, the easy path for a nonprofit society is often to settle. Lawsuits are expensive, time-consuming, and carry the risk of damaging a brand’s reputation. Had the ADA capitulated, it could have quietly removed the expressions of concern and avoided years of litigation. Instead, the organization chose to fight for the integrity of its literature. It stood by its editors and its peer-review process, ultimately prevailing when the U.S. District Court of Massachusetts dismissed the case. Following the legal victory, Diabetes moved forward with the retraction of the four tainted papers. This was the "swagger" of 2015—a commitment to truth and the scientific record, regardless of the cost or the power of the person challenging it.
It was this very courage that led to the ADA being named the "champions of decisive action" in 2017. However, the 2026 version of the ADA seems to have misinterpreted the concept of "policing the literature." Rather than policing the accuracy of the data within its pages, it has resorted to using actual police to prevent people from reading those pages. This pivot suggests a profound loss of institutional identity. The ADA’s current CEO, Charles Henderson, suggested in his apology that the organization’s primary goal is to advocate for NIH funding and support the research community. Yet, the logic is fundamentally flawed: if a medical society is so afraid of offending the "purse strings" of the government that it muzzles its own members for citing its own journals, it has already lost its ability to advocate effectively.
The broader context of 2026 adds a layer of political tension to this debacle. We are living in an era where the stakes of political dissent have been significantly raised. The federal government has increasingly used its power to intimidate critics within the scientific and journalistic communities. From federal charges filed against individuals for seemingly innocuous political social media posts to the Department of Justice subpoenaing journalists and their families, the climate is one of heightened fear. In such an environment, the pressure on organizations like the ADA to "stay in line" to protect their funding is immense. However, as Marcus and Oransky have noted, fears of future intimidation do not excuse preemptive capitulation. When a scientific body silences its members to appease a political administration, it undermines the very foundation of evidence-based dialogue.
The fallout from this incident has effectively disqualified the ADA’s current leadership from any future recognition of integrity. The Center for Scientific Integrity recently announced the "Ctrl-Z Award," a successor to the DiRT Award, designed to honor those who correct the scientific record at great personal or professional cost. While the 2015 ADA might have been a candidate, the 2026 ADA represents the antithesis of this spirit. Instead of correcting the record, they have attempted to hide it behind security cordons.
The damage to the ADA’s reputation may be long-lasting. Scientific societies exist to provide a forum for the exchange of ideas, even—and perhaps especially—when those ideas are critical of the status quo. By prioritizing a "nonpartisan environment" over the free distribution of its own peer-reviewed content, the ADA has signaled that its allegiance is to political convenience rather than scientific truth. This "cowardice," as critics have labeled it, sends a dangerous message to the global research community: that the pursuit of government funding is a higher priority than the pursuit of scientific transparency.
As the ADA awaits the findings of its internal audit, the scientific community is watching closely. The restoration of trust will require more than a bureaucratic report; it will require a return to the principles that once made the ADA a leader in the field. The organization must reaffirm the editorial independence of its journals and prove that it can withstand political pressure without sacrificing its mission. The "justifiable swagger" of 2015 was built on the knowledge that the organization stood for something greater than its bottom line. If the ADA wishes to move past this self-made mess, it must rediscover that core conviction and recognize that true advocacy for science requires the courage to speak truth to power, even when that power holds the purse strings. Only then can it hope to reclaim its status as a defender of the scientific record rather than a silencer of it.

